Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianglidingxuan is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of hypertension and associated symptoms such as vertigo and headache. It is composed of multiple herbal ingredients, typically including Gastrodia elata (Tianma), Eucommia ulmoides (Duzhong), Uncaria rhynchophylla (Gouteng), and Scutellaria baicalensis (Huangqin). The preparation is designed to 'calm the liver and extinguish wind' (Ping Gan Xi Feng) and 'invigorate the blood to resolve stasis' in the context of TCM theory. Clinically, it is often evaluated as an adjunctive therapy to standard antihypertensive medications like amlodipine to improve blood pressure control and alleviate TCM-related syndromes such as irritability, dizziness, and insomnia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qianglidingxuan.